Clinical Trial Update: Hydroxychloroquine in Cystic Fibrosis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating hydroxychloroquine for cystic fibrosis, sponsored by Vanderbilt University, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Vanderbilt University | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED